Gender Differences in Nicotine Induced Dyslipidemia and Hyperglycemia in Mice


Cholesterol, lipid profile, metabolic syndrome, corticosterone, nicotine, mice.

How to Cite

Samina Bano, & Shabana Saeed. (2021). Gender Differences in Nicotine Induced Dyslipidemia and Hyperglycemia in Mice. Journal of Basic & Applied Sciences, 10, 33–38.


The purpose of this study is to examine the prevalence of metabolic syndrome in nicotine treated male and female mice and to evaluate gender related differences. For these purposes adult male and female BALB/C mice were subjected to chronic nicotine treatment (3.08mg/100ml in drinking water) for 4 weeks. Serum glucose, albumin, corticosterone and lipid profile levels were determined. Body weight changes were also monitored. We have found that nicotine treatment raises total cholesterol and glucose levels more in male as compared to female mice. Low density lipoprotein cholesterol (LDL-C) levels were increased by 35% (P<0.01) only in male mice. However rise in triglycerides were greater in females (28%) than males (21%) when compared with their respective controls. Serum albumin levels were increased in both sexes showing 13% greater increase in males as compared to females. However nicotine treatment had no effect on high density lipoprotein cholesterol, corticosterone levels and body weights in both genders. It is concluded that nicotine use is positively associated with LDL-C in males; the results are discussed in relation to prevalence of metabolic syndrome andrisk of cardiovascular events in nicotine users.


Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996; 19: 112-18.

Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-30.

Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus.J Clin Endocrinol Metab 1997; 82(11): 3619-24.

Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology 2003; 54: 507-30.

Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 1987; 5(1): 124-30.

Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease an update. J Am Coll Cardiol 2004; 43(10): 1731-7.

Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health. 2005; 43: 295-301.

Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med. 2006; 45: 1039-43.

Oh SW, Yoon YS, Lee ES, Kim WK, Park C, Lee S, et al. Association between cigarette smoking and metabolic syndrome: the Korea National Health and Nutrition Examination Survey (Brief Report). Diabetes Care2005; 28: 2064-66.

Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Biochem Biophys Res Commun 1993; 23: 630-40.

Steptoe A, Ayers S. Stress, health and illness. In: Sutton S,. Baum A, Johnston M, editors. The Sage Handbook of Health Psychology. London: Sage; 2004; p.169-96.

al’Absi M, Hatsukami D, Davis GL, Wittmers LE. Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 2004; 73: 267-78.

Bibi Z, Saeed S, Bano S. Metabolic and behavioral effect of nicotine on swim stressed mice, Journal of Pharmacy and Nutrition Sciences 2011; 1: 54-60.

Hultman E. Estimation of glucose by O-toludine method. Nature 1959; 183: 108.

Doumas BT and Biggs HG.Determination of serum albumin. Standard Methods in Clinical Chemistry 1972; 7: 175-88.

Glick, D, Von Redlich D, Levine S. Fluorimetric determination of corticosterone and cortisol in 0.02-0.05 millilitres of plasma or submilligram samples of adrenal tissue. Endocrinology 1964; 74:653-55.

Ashakumary L, Vijayammal PL. Effect of nicotine on lipoprotein metabolism in rats. Lipids 1997; 32(3): 311-5.

Heitzer T, Ylä-Herttuala S, Luoma J, Kurz S, Münzel T, Just H, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation 1996; 9: 1346-53.

MjøS OD. Lipid effects of smoking. American Heart Journal 1988; 115: 272-75.

Muscat JE, Harris RE. Haley NJ, Wynder EL. Cigarette smoking and plasma cholesterol. Am Heart J 1991; 121: 141-47.

Hellerstein MK, Benowitz NL, Neese RA, et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994; 93: 265-72.

Strohschneider T, Oberhoff M, Hanke H, Hannekum A, Karsch KR. Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques Clin Invest 1994; 72: 908-912.

Abd el Mohsen MM, Fahim AT, Otawi TM, Ismail NA. Nicotine and stress: Effect of sex hormones and lipid profile in female rats. Pharmacol Res 1997; 35(3): 181-7.

Grunberg NE, Popp KA, Bowen DJ, Nespor SM, Winders SE, Eury SE. Effects of chronic nicotine administration on insulin, glucose, epinephrine, and norepinephrine. Life Sci. 1988; 42(2): 161-70.

Uyama N, Geerts A, Reynaert H. Neural connections between the hypothalamus and the liver The Anatomical Record part A 2004; 280A: 808-20. http: //onlinelibrary.wiley. com/doi/10.1002/ar.a.20086/pdf

Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardio-vascular disease. J Am Coll Cardiol 2003; 41: 1044-7.

Cruz FC, DeLucia R, Planeta CS. Effects of chronic stress on nicotine-induced locomotor activity and corticosterone release in adult and adolescent rats. Addict Biol 2008; 13: 63-69.

Davis KW, Cepeda-Benito A, Harraid JH, Wellman PJ. Plasma corticosterone in the rat in response to nicotine and saline injections in a context previously paired or unpaired with nicotine.Psychopharmacology (Berl) 2005; 180(3): 466-72.

Lutfy K, Brown MC, Nerio N, Aimiuwu O, Tran B, Anghel A, et al. Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis. J. Neurochem. 2006; 99: 1321-27.

Matta SG, Fu Y, Valentine JD, Sharp BM. Response of the hypothalamic-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998; 23: 103-13.

Westfall TC. Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacology 1974; 13: 693-700.

Fuxe K, Andersson K, Eneroth P, Siegel RA, Agnati LF. Immobilization stress-induced changes in discrete hypothalamic catecholamine levels and turnover, their modulation by nicotine and relationship to neuroendocrine function. Acta Physiol Scand 1983; 117: 421-426.

Tsagarakis S., Holly JMP, Rees LH, Besser GM,Grossman A. (1988) Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor from the rat hypothalamus in vitro. Endocrinology 1988; 123: 1962-1969.

Fuxe K, Andersson K, Eneroth P, Harfstrand A, Agnati LF. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuro-endocrinology 1989; 14: 19-41.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.